Table 1.
Demographic and clinical characteristics of the 15 young adults with an advanced AVN disease without known cardiac disease at the time of first pacemaker implantation
| Variable | All patients | Female patients | Male patients | P valuea |
|---|---|---|---|---|
| N = 15 | N = 5 | N = 10 | ||
| Age at implant, (CI 25th–75th percentile) | 44 (31.7–46.7) | 37.5 (21.7–46.5) | 45.5 (40.5–48) | 0.51 |
| Atrioventricular conduction disturbance | 1.00 | |||
| ȃMobitz II—second-degree AV block, (%) | 2 (13.3%) | 1 (20%) | 1 (10%) | |
| ȃThird-degree AV block—intermittent, (%) | 8 (53.3%) | 3 (60%) | 5 (50%) | |
| ȃThird-degree AV block—permanent, (%) | 5 (33.3%) | 1 (20%) | 4 (40%) | |
| Presenting symptom | ||||
| ȃDizziness, (%) | 8 (53.3%) | 4 (80%) | 4 (40%) | 0.28 |
| ȃSyncope, (%) | 2 (13.3%) | 1 (20%) | 1 (10%) | 1.00 |
| ȃDyspnoea or fatigue, (%) | 6 (40%) | 3 (60%) | 3 (30%) | 0.33 |
| Comorbidity | ||||
| ȃHypertension, (%) | 3 (20%) | 1 (20%) | 2 (20%) | 1.00 |
| ȃDyslipidemia, (%) | 2 (13.3%) | 1 (20%) | 1 (10%) | 1.00 |
| ȃSmoking habit, (%) | 3 (20%) | 2 (40%) | 1 (10%) | 0.24 |
Fisher exact test for all but age (Mann Whitney U test).